SMS PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 226.1 INR | -1.30% |
|
+8.38% | +90.49% |
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing of active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel and lamotrigine. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +90.49% | 232M | |
| +20.78% | 43.29B | |
| +27.64% | 22.38B | |
| +19.25% | 15.51B | |
| +18.68% | 14.52B | |
| +54.64% | 12.93B | |
| -0.05% | 6.79B | |
| -11.39% | 6.56B | |
| +18.33% | 5.87B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- SMSPHARMA Stock
- News SMS Pharmaceuticals Limited
- SMS Pharmaceuticals to Raise Up to INR1.14 Billion from Convertible Warrants
